# Elevance Health Inc. (ELV)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $89.66B  
**Price:** $399.18 (-1.33%)

> Elevance Health, Inc. is a diversified health company headquartered in Indianapolis, Indiana. The company focuses on supporting health at every life stage by integrating medical, pharmacy, behavioral, and complex-care services. Elevance Health operates through several key segments. Its Health Benefits segment provides a broad range of commercial, Medicaid, Medicare, and specialty health plans to individuals, employers, and government programs. Through CarelonRx, it offers pharmacy benefit management solutions, including prescription management and related pharmacy services. Carelon Services delivers care management, analytics, and other clinical and administrative services aimed at coordinating and improving care quality. Together, these businesses enable Elevance Health to serve as a major player in the U.S. healthcare system, connecting health plans, care providers, and consumers to streamline access to care and support better health outcomes across diverse populations.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $199.13B | $177.95B | $7.20B | $5.66B | $25.21 |
| 2024 | $177.01B | $157.26B | $7.86B | $5.98B | $25.68 |
| 2023 | $171.34B | $154.05B | $8.50B | $5.99B | $25.22 |
| 2022 | $156.59B | $143.56B | $8.28B | $5.89B | $24.28 |
| 2021 | $138.64B | $127.74B | $7.56B | $6.16B | $24.95 |
| 2020 | $121.87B | $112.91B | $6.36B | $4.57B | $17.98 |
| 2019 | $104.21B | $102.22B | $6.00B | $4.81B | $18.47 |
| 2018 | $92.11B | $92.11B | $5.43B | $3.75B | $14.19 |
| 2017 | $90.04B | $90.04B | $4.17B | $3.84B | $14.35 |
| 2016 | $84.86B | — | $4.80B | $2.47B | $9.21 |
| 2015 | $79.16B | — | $4.75B | $2.56B | $9.38 |
| 2014 | $73.87B | — | $4.42B | $2.57B | $8.99 |
| 2013 | $71.02B | — | $4.00B | $2.49B | $8.20 |
| 2012 | $61.50B | $61.36B | $3.62B | $2.66B | $8.18 |
| 2011 | $60.71B | $60.71B | $3.78B | $2.65B | $7.25 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $121.49B | $77.47B | $43.88B | $9.49B | $31.90B |
| 2024 | $116.89B | $75.46B | $41.31B | $8.29B | $30.87B |
| 2023 | $108.93B | $69.52B | $39.31B | $6.53B | $24.89B |
| 2022 | $102.75B | $66.42B | $36.24B | $7.39B | $23.85B |
| 2021 | $97.46B | $61.29B | $36.09B | $4.88B | $22.76B |
| 2020 | $86.61B | $53.42B | $33.20B | $5.74B | $20.04B |
| 2019 | $77.45B | $45.73B | $31.73B | $4.94B | $19.39B |
| 2018 | $71.57B | $43.03B | $28.54B | $3.93B | $18.07B |
| 2017 | $70.54B | $44.04B | $26.50B | $3.61B | $18.66B |
| 2016 | $65.08B | $39.98B | $25.10B | $4.08B | $15.29B |
| 2015 | $61.72B | $38.67B | $23.05B | $2.11B | $15.32B |
| 2014 | $61.68B | $37.42B | $24.25B | $2.15B | $14.64B |
| 2013 | $59.57B | $34.81B | $24.77B | $1.58B | $14.09B |
| 2012 | $58.96B | $35.15B | $23.80B | $2.48B | $14.73B |
| 2011 | $52.16B | $28.88B | $23.29B | $2.20B | $9.74B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $4.29B | $1.12B | $3.17B |
| 2024 | $5.81B | $1.26B | $4.55B |
| 2023 | $8.06B | $1.30B | $6.76B |
| 2022 | $8.40B | $1.15B | $7.25B |
| 2021 | $8.36B | $1.09B | $7.28B |
| 2020 | $10.69B | $1.02B | $9.67B |
| 2019 | $6.06B | $1.08B | $4.98B |
| 2018 | $3.83B | $1.21B | $2.62B |
| 2017 | $4.18B | $791M | $3.39B |
| 2016 | $3.27B | $584M | $2.69B |
| 2015 | $4.21B | $638M | $3.57B |
| 2014 | $3.37B | $715M | $2.65B |
| 2013 | $3.05B | $647M | $2.41B |
| 2012 | $2.74B | $545M | $2.20B |
| 2011 | $3.37B | $520M | $2.85B |

Source: [CompaniesByCap](https://companiesbycap.com/company/ELV)